Clinical Trial

Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to observe the effects of daily personalized digital reminiscence sessions, conducted with the help of a digital conversational agent, and to determine whether these sessions lead to improvements in symptoms such as apathy and depression. The researchers therefore seek to observe whether this daily use can improve certain aspects of well-being, such as motivation, mood, sleep quality, quality of life, and engagement with the tool. The study also aims to assess whether simple reminders delivered via the application are sufficient to encourage regular use without external assistance. Participants will: * Use the reminiscence app for 25 days for 10-15 minutes. * Have a primary caregiver help personalize the app by sharing family memories, other relatives may optionally contribute in a private group. * Complete brief questionnaires at the start and during follow-up routine visits (for example, apathy and depression scales, sleep, and quality of life).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-17.
Trial Details
NCT Number NCT07237009
Lead Sponsor KompanionCare SAS
Collaborators: Clinical Research Units Hungary
Conditions Neurocognitive Disorders, Mild, Cognitive Impairment, Mild, Depression Mild, Apathy, Apathy in Dementia
Enrollment 80 participants
Start Date 2025-10-14
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-09